House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

834

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

February 28, 2014

Conditions
Asthma
Interventions
DRUG

ALK HDM AIT Placebo

Oral lyophilisate, Placebo, to be administered sublingually once daily

DRUG

ALK HDM AIT 6 DU

Oral lyophilisate, 6 DU, to be administered sublingually once daily for 14-18 months.

DRUG

ALK HDM AIT 12 DU

Oral lyophilisate, 12 DU, to be administered sublingually once daily for 14-18 months.

Trial Locations (1)

18057

Universitätsklinikum Rostock, Abteilung für Pneumologie Zentrum für Innere Medizin, Ernst Heydemann Strasse 6, Rostock

All Listed Sponsors
collaborator

Ergomed

INDUSTRY

collaborator

ACM Pivotal Global Central Laboratory

INDUSTRY

lead

ALK-Abelló A/S

INDUSTRY